GB0411537D0 - Nanoparticles comprising rna ligands - Google Patents

Nanoparticles comprising rna ligands

Info

Publication number
GB0411537D0
GB0411537D0 GBGB0411537.4A GB0411537A GB0411537D0 GB 0411537 D0 GB0411537 D0 GB 0411537D0 GB 0411537 A GB0411537 A GB 0411537A GB 0411537 D0 GB0411537 D0 GB 0411537D0
Authority
GB
United Kingdom
Prior art keywords
nanoparticles
rna ligands
ligands
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0411537.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Midatech Ltd
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Midatech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Midatech Ltd filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to GBGB0411537.4A priority Critical patent/GB0411537D0/en
Publication of GB0411537D0 publication Critical patent/GB0411537D0/en
Priority to EP10181903.5A priority patent/EP2330208B1/en
Priority to CN201210359631.3A priority patent/CN102872463B/en
Priority to ES10181903.5T priority patent/ES2655069T3/en
Priority to US11/597,215 priority patent/US20080213177A1/en
Priority to JP2007514090A priority patent/JP5398982B2/en
Priority to EP05746540.3A priority patent/EP1756289B1/en
Priority to CN2005800240377A priority patent/CN101180400B/en
Priority to ES05746540.3T priority patent/ES2533238T3/en
Priority to PCT/GB2005/002058 priority patent/WO2005116226A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0411537.4A 2004-05-24 2004-05-24 Nanoparticles comprising rna ligands Ceased GB0411537D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0411537.4A GB0411537D0 (en) 2004-05-24 2004-05-24 Nanoparticles comprising rna ligands
PCT/GB2005/002058 WO2005116226A2 (en) 2004-05-24 2005-05-24 Nanoparticles comprising rna ligands
US11/597,215 US20080213177A1 (en) 2004-05-24 2005-05-24 Nanoparticles Comprising Rna Ligands
CN201210359631.3A CN102872463B (en) 2004-05-24 2005-05-24 Nanoparticles comprising RNA ligands
ES10181903.5T ES2655069T3 (en) 2004-05-24 2005-05-24 Nanoparticles comprising RNA ligands
EP10181903.5A EP2330208B1 (en) 2004-05-24 2005-05-24 Nanoparticles comprising RNA ligands
JP2007514090A JP5398982B2 (en) 2004-05-24 2005-05-24 Nanoparticles containing RNA ligands
EP05746540.3A EP1756289B1 (en) 2004-05-24 2005-05-24 Nanoparticles comprising rna ligands
CN2005800240377A CN101180400B (en) 2004-05-24 2005-05-24 Nanoparticles comprising RNA ligands
ES05746540.3T ES2533238T3 (en) 2004-05-24 2005-05-24 Nanoparticles comprising RNA ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0411537.4A GB0411537D0 (en) 2004-05-24 2004-05-24 Nanoparticles comprising rna ligands

Publications (1)

Publication Number Publication Date
GB0411537D0 true GB0411537D0 (en) 2004-06-23

Family

ID=32607858

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0411537.4A Ceased GB0411537D0 (en) 2004-05-24 2004-05-24 Nanoparticles comprising rna ligands

Country Status (3)

Country Link
CN (2) CN102872463B (en)
ES (2) ES2655069T3 (en)
GB (1) GB0411537D0 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073856A2 (en) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
AU2009316286B2 (en) * 2008-11-24 2016-05-26 Northwestern University Polyvalent RNA-nanoparticle compositions
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
KR20170072367A (en) * 2009-04-15 2017-06-26 노오쓰웨스턴 유니버시티 Delivery of oligonucleotide-functionalized nanoparticles
CN102631687A (en) * 2012-05-07 2012-08-15 西安电子科技大学 Multifunctional magnetic nano-carrier for targeted delivery of microRNA, preparation method and application thereof
CA2873274C (en) * 2012-06-08 2021-06-01 Ethris Gmbh Pulmonary delivery of messenger rna
EP2865759B1 (en) * 2012-06-20 2017-05-17 NapaJen Pharma, Inc. Nucleic acid complex and nucleic acid-polysaccharide complex
US10894963B2 (en) 2013-07-25 2021-01-19 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
WO2015126502A2 (en) 2013-12-03 2015-08-27 Northwestern University Liposomal particles, methods of making same and uses thereof
CN106535876B (en) 2014-06-04 2020-09-11 埃克西奎雷股份有限公司 Multivalent delivery of immunomodulators through liposomal spherical nucleic acids for prophylactic or therapeutic applications
JP2017537619A (en) 2014-11-21 2017-12-21 ノースウェスタン ユニバーシティ Sequence-specific intracellular uptake of spherical nucleic acid nanoparticle complexes
CN111110846B (en) * 2018-10-30 2021-07-23 国家纳米科学中心 Metal-nucleic acid nano-particle and preparation method and application thereof
CN113413467A (en) * 2021-07-01 2021-09-21 清华大学 Carrier-free mRNA delivery method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2262018C (en) * 1996-07-29 2007-10-02 Nanosphere Llc Nanoparticles having oligonucleotides attached thereto and uses therefor
GB0025414D0 (en) * 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles

Also Published As

Publication number Publication date
ES2655069T3 (en) 2018-02-16
CN101180400B (en) 2013-07-10
ES2533238T3 (en) 2015-04-08
CN102872463B (en) 2015-04-08
CN102872463A (en) 2013-01-16
CN101180400A (en) 2008-05-14

Similar Documents

Publication Publication Date Title
EP1791567A4 (en) Chemically modified oligonucleotides
TWI350762B (en) Particulates
GB2429838B (en) Nanoparticles
EP1723162A4 (en) Anti-microrna oligonucleotide molecules
ZAA200500558S (en) Wheels
ZA200606647B (en) Particulates
DE502005003298D1 (en) Ls
ZA200607117B (en) Nucleic acid complexes
GB0411537D0 (en) Nanoparticles comprising rna ligands
ZAA200500685S (en) Wheels
GB0405200D0 (en) Combinations comprising alpha-2-delta ligands
GB0414278D0 (en) Nanoparticles
IL189265A0 (en) Ferrocene-diphosphine ligands
GB0414998D0 (en) Monodonor ligands
GB0426188D0 (en) DNA repeats
GB0423740D0 (en) Nanostructures
GB0402416D0 (en) Ligands
GB0403014D0 (en) Ligands
GB0418568D0 (en) Ligands
GB0410522D0 (en) Functionaliseable nanoparticles
GB0407915D0 (en) Nanoparticles
GB0407603D0 (en) Nanoparticles
GB0417107D0 (en) Genes II
GB0408629D0 (en) Gene
PL115054U1 (en) Straight filter

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)